BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16144894)

  • 1. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2005 Sep; 143(5):355-61. PubMed ID: 16144894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.
    Nelson HD; Huffman LH; Fu R; Harris EL;
    Ann Intern Med; 2005 Sep; 143(5):362-79. PubMed ID: 16144895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
    Bellcross CA; Leadbetter S; Alford SH; Peipins LA
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):728-35. PubMed ID: 23371291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome.
    Obstet Gynecol; 2009 Apr; 113(4):957-966. PubMed ID: 19305347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast-cancer risk in families with mutations in PALB2.
    Antoniou AC; Foulkes WD; Tischkowitz M
    N Engl J Med; 2014 Oct; 371(17):1651-2. PubMed ID: 25337756
    [No Abstract]   [Full Text] [Related]  

  • 8. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility.
    Robson ME; Storm CD; Weitzel J; Wollins DS; Offit K;
    J Clin Oncol; 2010 Feb; 28(5):893-901. PubMed ID: 20065170
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.
    Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
    Genet Med; 2009 Jan; 11(1):35-41. PubMed ID: 19125126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
    Ford D; Easton DF; Stratton M; Narod S; Goldgar D; Devilee P; Bishop DT; Weber B; Lenoir G; Chang-Claude J; Sobol H; Teare MD; Struewing J; Arason A; Scherneck S; Peto J; Rebbeck TR; Tonin P; Neuhausen S; Barkardottir R; Eyfjord J; Lynch H; Ponder BA; Gayther SA; Zelada-Hedman M
    Am J Hum Genet; 1998 Mar; 62(3):676-89. PubMed ID: 9497246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ENGAGE study: a 3-arm randomized hybrid type 1 effectiveness and implementation study of an in-home, collaborative PCP model of remote telegenetic services to increase uptake of cancer genetic services in childhood cancer survivors.
    Henderson TO; Allen MA; Mim R; Egleston B; Fleisher L; Elkin E; Oeffinger K; Krull K; Ofidis D; Mcleod B; Griffin H; Wood E; Cacioppo C; Weinberg M; Brown S; Howe S; McDonald A; Vukadinovich C; Alston S; Rinehart D; Armstrong GT; Bradbury AR
    BMC Health Serv Res; 2024 Feb; 24(1):253. PubMed ID: 38414045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cost-utility analysis of
    Lertwilaiwittaya P; Tantai N; Maneeon S; Kongbunrak S; Nonpanya N; Hurst ACE; Srinonprasert V; Pithukpakorn M
    Front Public Health; 2023; 11():1257668. PubMed ID: 38162618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial Cancer Risk Among Germline
    Sorouri K; Lynce F; Feltmate CM; Davis MR; Muto MG; Konstantinopoulos PA; Stover EH; Kurian AW; Hill SJ; Partridge AH; Tolaney SM; Garber JE; Bychkovsky BL
    JCO Precis Oncol; 2023 Sep; 7():e2300290. PubMed ID: 38061009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mainstreaming oncogenomics model: improving the identification of Lynch syndrome.
    O'Shea R; Crook A; Jacobs C; Kentwell M; Gleeson M; Tucker KM; Hampel H; Rahm AK; Taylor N; Lewis S; Rankin NM
    Front Oncol; 2023; 13():1140135. PubMed ID: 37305562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Educational Case: Ovarian neoplasms: A series of educational cases to review malignancies of epithelial, stromal, and germ cell origin.
    Tumas JB; Chan J
    Acad Pathol; 2023; 10(2):100080. PubMed ID: 37168283
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary outcomes of five-year survival for ovarian malignancies in profiled Serbian Oncology Centre.
    Gutic B; Bozanovic T; Mandic A; Dugalic S; Todorovic J; Dugalic MG; Sengul D; Detanac DA; Sengul I; Detanac D; Kesicioglu T; Soares Junior JM
    Clinics (Sao Paulo); 2023; 78():100204. PubMed ID: 37148829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing a deliberative democracy method with citizens of African ancestry to weigh pros and cons of targeted screening for hereditary breast and ovarian cancer risk.
    Guan Y; Pathak S; Ballard D; Veluswamy JK; McCullough LE; McBride CM; Gornick MC
    Front Public Health; 2022; 10():984926. PubMed ID: 36424974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicaid Expansions: Probing Medicaid's Filling of the Cancer Genetic Testing and Screening Space.
    Modell SM; Schlager L; Allen CG; Marcus G
    Healthcare (Basel); 2022 Jun; 10(6):. PubMed ID: 35742117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer genetic testing in marginalized groups during an era of evolving healthcare reform.
    Modell SM; Allen CG; Ponte A; Marcus G
    J Cancer Policy; 2021 Jun; 28():100275. PubMed ID: 35559905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical Issues of Digital Twins for Personalized Health Care Service: Preliminary Mapping Study.
    Huang PH; Kim KH; Schermer M
    J Med Internet Res; 2022 Jan; 24(1):e33081. PubMed ID: 35099399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.